This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Khera N, Zeliadt SB, Lee SJ . Economics of hematopoietic cell transplantation. Blood 2012; 120: 1545–1551.
Lee SJ, Klar N, Weeks JC, Antin JH . Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64–71.
Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA et al. The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia. Biol Blood Marrow Transplant 2010; 16: 1272–1281.
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 2008; 14: 197–207.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Frangoul, H., Crowe, D. Cost saving associated with implementing a stepwise approach to HLA typing of related donors before hematopoietic SCT. Bone Marrow Transplant 49, 850–851 (2014). https://doi.org/10.1038/bmt.2014.22
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.22
This article is cited by
-
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest
The Pharmacogenomics Journal (2017)